Please login to the form below

Not currently logged in
Email:
Password:

NovoThirteen

This page shows the latest NovoThirteen news and features for those working in and with pharma, biotech and healthcare.

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten

The product is already sold in Canada under the same brand name, and in the EU, Switzerland and Australia as NovoThirteen. ... Given the patient population for Tretten/NovoThirteen is so tiny sales are expected to be modest, although analysts at Jyske

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics